BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

855 related articles for article (PubMed ID: 29372536)

  • 1. Biological Therapies for Eosinophilic Esophagitis: Where Do We Stand?
    Ko E; Chehade M
    Clin Rev Allergy Immunol; 2018 Oct; 55(2):205-216. PubMed ID: 29372536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal Antibodies for Treatment of Eosinophilic Esophagitis.
    Eskian M; Khorasanizadeh M; Assa'ad AH; Rezaei N
    Clin Rev Allergy Immunol; 2018 Aug; 55(1):88-98. PubMed ID: 29234969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biologic Therapies for Immunoglobulin E-mediated Food Allergy and Eosinophilic Esophagitis.
    Otani IM; Nadeau KC
    Immunol Allergy Clin North Am; 2017 May; 37(2):369-396. PubMed ID: 28366483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological treatments for eosinophilic esophagitis: current options and emerging therapies.
    Lucendo AJ
    Expert Rev Clin Immunol; 2020 Jan; 16(1):63-77. PubMed ID: 31842634
    [No Abstract]   [Full Text] [Related]  

  • 5. Eosinophilic Esophagitis: the Potential Role of Biologics in its Treatment.
    Choudhury S; Baker S
    Clin Rev Allergy Immunol; 2020 Oct; 59(2):150-159. PubMed ID: 31175521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eosinophils in Eosinophilic Esophagitis: The Road to Fibrostenosis is Paved With Good Intentions.
    Doyle AD; Masuda MY; Kita H; Wright BL
    Front Immunol; 2020; 11():603295. PubMed ID: 33335531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of eosinophilic esophagitis in the pediatric patient: an evidence-based approach.
    Munoz-Persy M; Lucendo AJ
    Eur J Pediatr; 2018 May; 177(5):649-663. PubMed ID: 29549437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical and dietary management of eosinophilic esophagitis.
    Nhu QM; Aceves SS
    Ann Allergy Asthma Immunol; 2018 Aug; 121(2):156-161. PubMed ID: 29753831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eosinophilic Esophagitis: Impact of Latest Insights Into Pathophysiology on Therapeutic Strategies.
    Schoepfer A; Safroneeva E; Straumann A
    Dig Dis; 2016; 34(5):462-8. PubMed ID: 27333298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An antibody against IL-5 reduces numbers of esophageal intraepithelial eosinophils in children with eosinophilic esophagitis.
    Assa'ad AH; Gupta SK; Collins MH; Thomson M; Heath AT; Smith DA; Perschy TL; Jurgensen CH; Ortega HG; Aceves SS
    Gastroenterology; 2011 Nov; 141(5):1593-604. PubMed ID: 21835135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapeutic approaches for the treatment of eosinophilic esophagitis.
    Cianferoni A; Spergel JM
    Immunotherapy; 2014; 6(3):321-31. PubMed ID: 24762076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous anti-IL-13 mAb QAX576 for the treatment of eosinophilic esophagitis.
    Rothenberg ME; Wen T; Greenberg A; Alpan O; Enav B; Hirano I; Nadeau K; Kaiser S; Peters T; Perez A; Jones I; Arm JP; Strieter RM; Sabo R; Gunawardena KA
    J Allergy Clin Immunol; 2015 Feb; 135(2):500-7. PubMed ID: 25226850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of the Environment in Eosinophilic Esophagitis.
    Dowling PJ; Neuhaus H; Polk BI
    Clin Rev Allergy Immunol; 2019 Dec; 57(3):330-339. PubMed ID: 30032346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eosinophilic esophagitis is characterized by a non-IgE-mediated food hypersensitivity.
    Simon D; Cianferoni A; Spergel JM; Aceves S; Holbreich M; Venter C; Rothenberg ME; Terreehorst I; Muraro A; Lucendo AJ; Schoepfer A; Straumann A; Simon HU
    Allergy; 2016 May; 71(5):611-20. PubMed ID: 26799684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eosinophilic esophagitis: Pathophysiology, diagnosis, and management.
    Vinit C; Dieme A; Courbage S; Dehaine C; Dufeu CM; Jacquemot S; Lajus M; Montigny L; Payen E; Yang DD; Dupont C
    Arch Pediatr; 2019 Apr; 26(3):182-190. PubMed ID: 30827775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacotherapies for the Treatment of Eosinophilic Esophagitis: State of the Art Review.
    de Rooij WE; Dellon ES; Parker CE; Feagan BG; Jairath V; Ma C; Bredenoord AJ
    Drugs; 2019 Sep; 79(13):1419-1434. PubMed ID: 31352605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eosinophilic esophagitis: current perspectives from diagnosis to management.
    Moawad FJ; Cheng E; Schoepfer A; Al-Haddad S; Bellizzi AM; Dawson H; El-Zimaity H; Guindi M; Penagini R; Safrooneva E; Chehade M
    Ann N Y Acad Sci; 2016 Sep; 1380(1):204-217. PubMed ID: 27467185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eosinophilic esophagitis: an autoimmune esophageal disorder.
    Malhotra N; Levine J
    Curr Probl Pediatr Adolesc Health Care; 2014 Dec; 44(11):335-40. PubMed ID: 25499460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated expression of activated T
    Cianferoni A; Ruffner MA; Guzek R; Guan S; Brown-Whitehorn T; Muir A; Spergel JM
    Ann Allergy Asthma Immunol; 2018 Feb; 120(2):177-183.e2. PubMed ID: 29289462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eosinophilic Esophagitis: an Important Comorbid Condition of Asthma?
    Durrani SR; Mukkada VA; Guilbert TW
    Clin Rev Allergy Immunol; 2018 Aug; 55(1):56-64. PubMed ID: 29455359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.